Biological Products, (No Diagnostic Substances) — Ranked by Net Income
SIC 2836 · Annual figures from SEC 10-K filings
These rankings show the largest Biological Products, (No Diagnostic Substances) companies by net income, based on the most recent fiscal year data reported in their annual 10-K filings with the SEC. Only companies with XBRL-tagged financial data are included. Use the tabs below to switch between revenue, net income, and total assets.
| # | Company | Net Income | Fiscal Year |
|---|---|---|---|
| 1 | GILEAD SCIENCES, INC. GILD | $8.51B | FY2025 |
| 2 | AMGEN INC AMGN | $7.71B | FY2025 |
| 3 | BIOGEN INC. BIIB | $1.29B | FY2025 |
| 4 | EXELIXIS, INC. EXEL | $782.57M | FY2025 |
| 5 | NEUROCRINE BIOSCIENCES INC NBIX | $478.60M | FY2025 |
| 6 | NOVAVAX INC NVAX | $440.30M | FY2025 |
| 7 | HALOZYME THERAPEUTICS, INC. HALO | $316.89M | FY2025 |
| 8 | BIOCRYST PHARMACEUTICALS INC BCRX | $263.86M | FY2025 |
| 9 | Krystal Biotech, Inc. KRYS | $204.83M | FY2025 |
| 10 | Coherus Oncology, Inc. CHRS | $168.02M | FY2025 |
| 11 | ADMA BIOLOGICS, INC. ADMA | $146.93M | FY2025 |
| 12 | BIO-TECHNE Corp TECH | $73.40M | FY2025 |
| 13 | ELUTIA INC. ELUT | $53.38M | FY2025 |
| 14 | REPLIGEN CORP RGEN | $48.89M | FY2025 |
| 15 | Atara Biotherapeutics, Inc. ATRA | $32.69M | FY2025 |
| 16 | PharmaCyte Biotech, Inc. PMCB | $30.66M | FY2025 |
| 17 | Black Diamond Therapeutics, Inc. BDTX | $22.37M | FY2025 |
| 18 | Vericel Corp VCEL | $16.52M | FY2025 |
| 19 | Vaxart, Inc. VXRT | $16.33M | FY2025 |
| 20 | SAB Biotherapeutics, Inc. SABSW | $13.27M | FY2025 |
| 21 | Voyager Acquisition Corp./Cayman Islands VACHW | $8.99M | FY2025 |
| 22 | CHAMPIONS ONCOLOGY, INC. CSBR | $4.70M | FY2025 |
| 23 | Abpro Holdings, Inc. ABPWW | $2.82M | FY2023 |
| 24 | Black Hawk Acquisition Corp BKHAU | $1.33M | FY2025 |
| 25 | Green Planet Bio Engineering Co. Ltd. GPLB | ($35,842) | FY2025 |
| 26 | Agentix Corp. AGTX | ($567,048) | FY2025 |
| 27 | Mosaic ImmunoEngineering Inc. CPMV | ($687,846) | FY2025 |
| 28 | FutureTech II Acquisition Corp. FTII | ($746,953) | FY2024 |
| 29 | LadRx Corp LADX | ($1.59M) | FY2024 |
| 30 | WINDTREE THERAPEUTICS INC /DE/ WINTW | ($1.79M) | FY2024 |
| 31 | VivoSim Labs, INC. VIVS | ($2.49M) | FY2025 |
| 32 | Viskase Holdings, Inc. ENZN | ($3.41M) | FY2025 |
| 33 | ADAPTIN BIO, INC. APTN | ($5.17M) | FY2025 |
| 34 | Zeo ScientifiX, Inc. ZEOX | ($5.52M) | FY2024 |
| 35 | Scinai Immunotherapeutics Ltd. SCNI | ($5.80M) | FY2022 |
| 36 | TC BioPharm (Holdings) plc TCBWF | ($5.91M) | FY2023 |
| 37 | Eloxx Pharmaceuticals, Inc. ELOX | ($6.00M) | FY2025 |
| 38 | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ | ($6.00M) | FY2025 |
| 39 | Protalix BioTherapeutics, Inc. PLX | ($6.60M) | FY2025 |
| 40 | DYADIC INTERNATIONAL INC DYAI | ($7.36M) | FY2025 |
| 41 | CURIS INC CRIS | ($7.58M) | FY2025 |
| 42 | BioCardia, Inc. BCDA | ($8.23M) | FY2025 |
| 43 | EXOZYMES INC. EXOZ | ($9.16M) | FY2025 |
| 44 | Century Therapeutics, Inc. IPSC | ($9.58M) | FY2025 |
| 45 | FENNEC PHARMACEUTICALS INC. FENC | ($9.74M) | FY2025 |
| 46 | Liminatus Pharma, Inc. LIMNW | ($10.21M) | FY2025 |
| 47 | BRAINSTORM CELL THERAPEUTICS INC. BCLI | ($10.31M) | FY2025 |
| 48 | Greenland Mines Ltd GRMLW | ($10.55M) | FY2025 |
| 49 | Entera Bio Ltd. ENTX | ($11.44M) | FY2025 |
| 50 | INTENSITY THERAPEUTICS, INC. INTS | ($11.61M) | FY2025 |